Cradle is a "biotech startup utilizing generative AI to aid in the design and engineering of proteins," setting a new standard in the efficiency and effectiveness of biological research and development.
Visit Cradle

Cradle represents a remarkable stride in the biotechnology sector, especially in the realm of protein design. It's a platform that leverages the power of generative AI to assist scientists in designing and engineering proteins. This innovative approach promises to revolutionize how we understand and manipulate the building blocks of life.

Revolutionizing Protein Design

The heart of Cradle lies in its ability to make the protein design process more efficient and effective. By using generative AI, Cradle aids biologists in creating improved proteins rapidly, thereby accelerating research and development. This technology is particularly vital in a field that traditionally involves extensive time and resource investments. For instance, biopharmaceutical companies often spend millions and several years on R&D to prepare a single potential product for clinical trials, with only a modest success rate. Cradle's technology addresses these challenges by drastically speeding up the design and optimization process, leading to more successful experiments and faster project progression.

User-Friendly and Secure Platform

Cradle is designed to be user-friendly, fitting seamlessly into scientists' existing workflows. It simplifies the process of setting up assays and objectives, generating sequences, and testing in the lab. Moreover, Cradle prioritizes privacy and security. The data and sequences handled by Cradle are private, ensuring that only authorized personnel have access. This approach provides peace of mind regarding intellectual property and data security, crucial aspects in the research domain.

Industry Recognition and Expansion

Cradle's innovative approach has attracted significant attention and funding, indicative of its potential and effectiveness. It has raised substantial funds, including a $24 million Series A funding round, which is being used to accelerate growth, expand its team, and enhance product development and sales capabilities. The platform has also formed partnerships with industry leaders, further validating its utility and impact in the field of biotechnology.

Global Team and Culture

Cradle's team, split between Zurich and Amsterdam, comprises experts in synthetic biology, machine learning, and developer tools. The diverse team brings together the best minds in biology, design, and engineering. The company culture emphasizes tackling significant challenges in machine learning and biology, with a deep commitment to impacting the world positively.


Cradle is not just an AI platform; it's a transformative force in biotechnology. By enabling faster, more efficient protein design, it opens new possibilities in health, environmental solutions, and beyond. Cradle is a testament to the power of AI in revolutionizing scientific research, making complex processes more accessible and manageable.

About the author
Robert Harris

Robert Harris

I am a zealous AI info-collector and reporter, shining light on the latest AI advancements. Through various channels, I encapsulate and share innovation with a broader audience.

Great! You’ve successfully signed up.

Welcome back! You've successfully signed in.

You've successfully subscribed to OpenDigg.

Success! Check your email for magic link to sign-in.

Success! Your billing info has been updated.

Your billing was not updated.